Healthcare Reporter India
SEE OTHER BRANDS

Get your fresh news on health and wellness in India

Healthcare Reporter India: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Reporter India.

Press releases published on August 28, 2025

Medcan and Avaamo Announce Innovative Collaboration to Enhance Client Experience Through AI

Medcan and Avaamo Announce Innovative Collaboration to Enhance Client Experience Through AI

LOS ALTOS, CA, UNITED STATES, August 28, 2025 /⁨EINPresswire.com⁩/ -- Avaamo, a leader in Agentic AI, has announced that it has undertaken a modernization project with Canadian-based Medcan Health Management to implement next-generation AI-powered client …

Summirow Dental Hospital Introduces EMS Guided Biofilm Therapy in Surat

Summirow Dental Hospital Introduces EMS Guided Biofilm Therapy in Surat

Summirow Dental brings EMS Guided Biofilm Therapy to Surat—painless, precise, and safe dental cleaning for long-term oral health. SURAT, GUJARAT, INDIA, August 28, 2025 /⁨EINPresswire.com⁩/ -- Summirow Dental Hospital has announced the launch of EMS …

Hodgkin’s Lymphoma Market Set to Reach New Heights by 2034 with Innovative Therapies and Clinical Successes | DelveInsight

Hodgkin’s Lymphoma Market Set to Reach New Heights by 2034 with Innovative Therapies and Clinical Successes | DelveInsight

New York, USA, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Hodgkin’s Lymphoma Market Set to Reach New Heights by 2034 with Innovative Therapies and Clinical Successes | DelveInsight The Hodgkin’s lymphoma market is witnessing steady growth driven by rising …

Antisense Oligonucleotide Therapeutics Clinical Trial Pipeline Appears Robust With 70+ Key Pharma Companies Actively Working in the Domain | DelveInsight

Antisense Oligonucleotide Therapeutics Clinical Trial Pipeline Appears Robust With 70+ Key Pharma Companies Actively Working in the Domain | DelveInsight

New York, USA, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Antisense Oligonucleotide Therapeutics Clinical Trial Pipeline Appears Robust With 70+ Key Pharma Companies Actively Working in the Domain | DelveInsight Antisense oligonucleotides (ASOs) are gaining …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions